197 related articles for article (PubMed ID: 11475502)
1. Think INN, prescribe INN, dispense INN: good professional practice.
Prescrire Int; 2000 Dec; 9(50):184-90. PubMed ID: 11475502
[TBL] [Abstract][Full Text] [Related]
2. [Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders].
Fraeyman J; De Winter J; De Loof H; Van Hal G; Beutels P; Remmen R; De Meyer GR
J Pharm Belg; 2013 Jun; (2):18-31. PubMed ID: 23798183
[TBL] [Abstract][Full Text] [Related]
3. INN-based prescribing: a good practice not widely adopted in France.
Prescrire Int; 2011; 20(118):191-2. PubMed ID: 21755621
[TBL] [Abstract][Full Text] [Related]
4. How INNs are created. Making drug names safer by contributing to INN selection.
Prescrire Int; 2015 Jun; 24(161):162-5. PubMed ID: 26436175
[TBL] [Abstract][Full Text] [Related]
5. Common stems: international nonproprietary names (INNs): common INN stems provide key information.
Prescrire Int; 2007 Oct; 16(91):192. PubMed ID: 17926829
[No Abstract] [Full Text] [Related]
6. [Evaluation of prescription practices and of the rational use of medicines in Niger].
Mallet HP; Njikam A; Scouflaire SM
Sante; 2001; 11(3):185-93. PubMed ID: 11641083
[TBL] [Abstract][Full Text] [Related]
7. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
9. Operational rules for the implementation of INN prescribing.
Van Bever E; Wirtz VJ; Azermai M; De Loof G; Christiaens T; Nicolas L; Van Bortel L; Vander Stichele R
Int J Med Inform; 2014 Jan; 83(1):47-56. PubMed ID: 24168761
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive drug prescribing in Grampian.
Ross S; Macleod MJ
Br J Clin Pharmacol; 2005 Sep; 60(3):300-5. PubMed ID: 16120069
[TBL] [Abstract][Full Text] [Related]
11. Obstacles to the universal application of INNs.
Prescrire Int; 2014 Oct; 23(153):248-51. PubMed ID: 25964979
[TBL] [Abstract][Full Text] [Related]
12. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.
Liu YM; Yang YH; Hsieh CR
J Health Econ; 2009 Mar; 28(2):341-9. PubMed ID: 19091433
[TBL] [Abstract][Full Text] [Related]
13. Attitudes of physicians and pharmacists towards International Non-proprietary Name prescribing in Belgium.
Van Bever E; Elseviers M; Plovie M; Vandeputte L; Van Bortel L; Vander Stichele R
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):264-72. PubMed ID: 25155133
[TBL] [Abstract][Full Text] [Related]
14. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
Kwo EC; Kamat P; Steinman MA
Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
[TBL] [Abstract][Full Text] [Related]
15. Generics: what's in a name?
Keith LG; Oleszczuk JJ; Stika CS; Stine S
Int J Fertil Womens Med; 1998; 43(3):139-49. PubMed ID: 9692536
[TBL] [Abstract][Full Text] [Related]
16. Medication errors resulting from the confusion of drug names.
Aronson JK
Expert Opin Drug Saf; 2004 May; 3(3):167-72. PubMed ID: 15155145
[TBL] [Abstract][Full Text] [Related]
17. Assessing prescribing and patient care indicators for children under five years old with malaria and other disease conditions in public primary health care facilities.
Nsimba SE
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):206-14. PubMed ID: 16771236
[TBL] [Abstract][Full Text] [Related]
18. INN or brand name drug prescriptions: a multilevel, cross-sectional study in general practice.
De Bruyne F; Ponçon A; Giai J; Dode X; Darmon D; Colin C; Gueyffier F; Letrilliart L
Eur J Clin Pharmacol; 2019 Feb; 75(2):275-283. PubMed ID: 30368571
[TBL] [Abstract][Full Text] [Related]
19. [Development of the database on nonproprietary names of drugs].
Hashiba S; Takenaka Y; Nakadate M
Eisei Shikenjo Hokoku; 1989; (107):141-5. PubMed ID: 2636918
[TBL] [Abstract][Full Text] [Related]
20. Neuropharmacology and mental health nurse prescribers.
Skingsley D; Bradley EJ; Nolan P
J Clin Nurs; 2006 Aug; 15(8):989-97. PubMed ID: 16879543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
